China News Service, Beijing, September 24 (Reporter Sun Zifa) The 3rd China Stem Cell and Regenerative Medicine Collaborative Innovation Platform Conference and Standards Conference was held in Huairou, Beijing on September 24, officially releasing a series of related standards in the field of stem cells, including China's leading The world's first stem cell international standard ISO 24603 "General Requirements for Human and Mouse Pluripotent Stem Cells", a national standard "General Principles of Cell Sterility Testing" and "Technical Specifications for Ethical Review of Human Stem Cell Research" and other 7 group standards.

　　ISO 24603 "General Requirements for Human and Mouse Pluripotent Stem Cells" is the first stem cell standard in the ISO system of the International Organization for Standardization, which specifies the establishment and culture, biological characteristics, quality control, information management, distribution and transportation of pluripotent stem cells and other requirements.

China released the world's first international standard for stem cells, which has received wide attention and high praise from Chinese and foreign experts in the field of stem cells and standards.

　　Academician Chen Yeguang, president of the Chinese Society of Cell Biology, believes that this is a necessary step in the development of stem cells in China, and it is also a very important step, which is of great significance to the standardization of the entire field and human health.

Academician Ji Weizhi, president of the Stem Cell Biology Branch of the Chinese Society for Cell Biology, believes that the release of the first international standard for stem cells shows that China's basic research in this field and some methods and technologies are already in the world's top echelon.

Academician Wang Songling of the Stem Cell Biology Branch believes that the release of the ISO 24603 international standard is a zero breakthrough in the field of stem cells, and has contributed Chinese wisdom and Chinese solutions to the stem cell field all over the world.

At the 3rd China Stem Cell and Regenerative Medicine Collaborative Innovation Platform Conference and Standard Conference, experts and scholars in the field of stem cells answered questions from the media.

Photo by China News Agency reporter Sun Zifa

　　George Dagher, the convener of WG2 of the International Organization for Standardization Biotechnology Committee, believes that the ISO 24603 international standard provides requirements for the identification of pluripotent stem cells to establish and maintain characteristics. It is an international consensus reached by experts from various countries based on ISO and is the key to the field of stem cells. and the necessary step.

Christine L. Mummery, member of the Steering Committee of the International Stem Cell Society and former president of the International Stem Cell Society, spoke highly of the achievements of China's stem cell standards and expected the work of China's stem cell standards to establish an international benchmark for the stem cell field.

Glyn Stacey, a member of the International Organization for Standardization Biotechnology Committee and a member of the International Stem Cell Society Standards Steering Committee, believes that the ISO 24603 formulation process is a long-term process full of various challenges and needs to deal with various technical issues. This standard is the first international standard in the field of stem cells, which is a milestone achievement.

　　Zheng Jian, deputy director of the Basic Research Department of the Ministry of Science and Technology of China, said that the international standard ISO 24603 is not only an access certificate for the world science and technology stage, but also provides strong support for the development of stem cell-related industries and injects scientific and technological innovation into China's life and health field. A new dose of "cardiac".

Xu Hang, deputy director of the Science and Technology Promotion and Development Bureau of the Chinese Academy of Sciences, believes that the ISO 24603 international standard is the first international standard in the field of stem cells led by China and participated by experts from Japan, Germany, Italy, the United Kingdom, the United States and other countries, and it is also China's international status in the field of stem cells. important manifestation.

Group photo of experts and representatives of the 3rd China Stem Cell and Regenerative Medicine Collaborative Innovation Platform Conference and Standard Conference.

Photo by China News Agency reporter Sun Zifa

　　The newly released stem cell group standards also include "human natural killer cells", "human midbrain dopaminergic neural precursor cells", "human neural stem cells", "human intestinal cancer organoids", "human intestinal organoids", "human stem cell-derived extracellular". General Requirements for Vesicle Preparation.

These international standards, national standards and group standards cover scientific research, clinical and industrial aspects, and systematically stipulate human stem cell research ethics, key quality attributes and quality control of stem cells and their derivatives, and ultimately form a basic consensus in the field of stem cells in China. It is also the technical support and basic guarantee for the industrialization of stem cells.

　　At the meeting on the same day, Academician Bian Xiuwu, chairman of the China Stem Cell and Regenerative Medicine Collaborative Innovation Platform, made an annual work report, saying that the platform will continue to work hard in stem cell research, clinical and industrial transformation and related policy formulation in the future, and assume its own social responsibility.

At the same time, the China Stem Cell and Regenerative Medicine Collaborative Innovation Platform, the Stem Cell Branch of the Chinese Society for Cell Biology, and the Standard Working Committee of the Chinese Society for Cell Biology also jointly initiated and signed the "Stem Cell Industry Practitioners Self-discipline Declaration", calling on Chinese stem cell practitioners to shoulder social responsibilities. , Pursue excellence, practice industry self-discipline, and jointly promote and maintain the healthy development of the stem cell industry.

Academician Bian Xiuwu made the annual work report of the China Stem Cell and Regenerative Medicine Collaborative Innovation Platform.

Photo by China News Agency reporter Sun Zifa

　　It is understood that the China Stem Cell and Regenerative Medicine Collaborative Innovation Platform was established in September 2019 led by the National Stem Cell Resource Bank. It is a professional, open and shared social organization voluntarily formed on the basis of equality, mutual benefit, sharing and cooperation. .

The platform vigorously promotes the combination of production, learning, research and application, aiming to promote the standardization, specialization and scale of the stem cell industry, and enhance the overall development level and competitiveness of China's biopharmaceutical industry.

(Finish)